Non-complementaemic urticarial vasculitis: Successful treatment with the IL-1 receptor antagonist, anakinra [3]

Scandinavian Journal of Rheumatology

Volumn 36, Issue 3, 2007, Pages 236-237

  Botsios, C ^a   Sfriso, P ^a   Punzi, L ^a   Todesco, S ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; METHOTREXATE; NAPROXEN; PREDNISONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; BONE MARROW BIOPSY; CASE REPORT; CELL SWELLING; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ERYTHROCYTE; ERYTHROCYTE SEDIMENTATION RATE; EXTRAVASATION; FEVER; HUMAN; LETTER; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; SYMPTOM; THERAPY EFFECT; URTICARIA; VASCULITIS;

HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MIDDLE AGED; URTICARIA; VASCULITIS, HYPERSENSITIVITY;

EID: 34547394924     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740600938647     Document Type: Letter

References (7)

1. Gibson LE, Su WPD. Cutaneous vasculitis. Rheum Dis Clin North Am 1995;21:1097-113.
2. Wisnieski JJ. Urticarial vasculitis. Curr Opin Rheumatol 2000;12:24-31.
3. Dinarello CA. The many worlds of reducing interleukin-1. Arthritis Rheum 2005;52:1960-7.
4. Soter NA. Clinical presentations and mechanisms of necrotizing angitis of the skin. J Invest Dermatol 1976;67:354-9.
5. Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, et al. The role of cytokines in Henoch Schönlein purpura. Scand J Rheumatol 1997;26:456-60.
6. Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum 2005;52:1794-803.
7. Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005;201:1479-86.